SlideShare a Scribd company logo
Pulmonary edema
Dr.Gireesh kumar.K.P
Pulmonary edema and cardiac failure
• Pulmonary edema is fluid accumulation in the tissue and
air spaces of the lungs. It leads to impaired gas exchange
and may cause respiratory failure.
• Cardiac failure is defined as a state in which the heart can
not maintain an adequate cardiac output or can do so
with an elevated filling pressure
Left ventricular failure - and causes
• In left ventricular systolic failure, there is reduced cardiac
contractility, where as in diastolic heart failure there is
impaired cardiac relaxation and abnormal ventricular
filling.
• Left ventricular systolic dysfunction - cases are due to
chronic coronary artery disease, MI or chronic angina.
Other causes of left ventricular systolic dysfunction
include idiopathic dilated cardiomyopathy, valvular heart
disease, hypertensive heart disease, toxin-induced
cardiomyopathies (ie, alcohol and doxorubicin), and
congenital heart disease.
Triggers of cardiac failure
• Infections, fever, sepsis , Anemia ,Beriberi ,Thyrotoxicosis
• Cardiac arrhythmias, Infective endocarditis
• Excess salt/fluid intake, Stress ,Electrolyte disturbances-
potassium, magnesium
• Steroids, NSAIDS
• Negative inotropes e.g. Calcium channel blockers, such
as verapamil & diltiazem, and Beta blockers
Clinical features of cardiac failure
Symptoms Signs
Fatigue,Exercise intolerance
Dyspnea on exertion
Orthopnea, PND
Presyncope, Syncope
Palpitation
Angina
Pedal oedema
Ascites
Elevated JVP
Hepatic congestion,
Hepatosplenomegaly
Pulmonary oedema(Basal
crepitations)
Investigations
• Hb % (anaemia to be ruled out)
• Thyroid function test
• Electrolytes – potassium, magnesium, sodium
• Serum creatinine (renal failure):
Chest X ray (pulmonary oedema)
• DD:Cardiogenic
pulmonary edema,
• ARDS,Viral pneumonia,
Eosinophilic
pneumonia,TB
B-type natriuretic peptide
• BNP is a 32 amino acid polypeptide secreted by the ventricles of
the heart in response to excessive stretching of heart muscle cells
• BNP is increased in patients with left ventricular dysfunction, with
or without symptoms (BNP accurately reflects current ventricular
status, as its half-life is 20 minutes,
• Levels above 500 pg/ml are generally considered to be positive,
Levels between 100 and 500 pg/ml the test is considered
inconclusive
• BNP can be elevated in renal failure, in the absence of heart
failure.
Other investigations
• ECG (Ischaemic changes)
• TMT (Ischaemic changes) in stable cases only
• ECHO(Low Ejection fraction, valvular lesions)
• USG abdomen (congestive hepatosplenomegaly)
Acute management
• Oxygen inhalation
• Propped up position /45O
head ed elevation
• S/L Nitroglycerine and IV NTG (if BP is high)
• IV Furosemide 40-80 mg IV , repeat if needed
• Inotropes (NA/Dopamine, Dobutamine) in hypotension
• Non invasive ventilation(BIPAP)
Diuretics
• Diuretics produces symptomatic relief
• Start with a thiazide diuretic in very mild failure
(Hydrochlorothiazide 12.5 – 25 mg) OR a loop diuretic
(Furosemide 40mg : Lasix 40 ®)
• Add a potassium-sparing agent, which can reduce
potential hypokalemia (Spironolactone 25 mg)
• Best option Furosemide + Spironolactone
• Lasilactone ® (Frusemide/Spironolactone- 20mg/50mg)
Ionotropes
• Sympathomimetic agents
– Dobutamine 2.5 – 15 mcg/kg/min infusion
– Dopamine 2 – 8 mcg /kg /min infusion
• Phosphodiesterase inhibitors
– Milrinone 50 mcg/kg IV bolus over 10 minutes then 0.375 –
0.75 mcg/kg/min,
– Amrinone.
– Levosimendan
Salt and water
• 2 gm salt , 1 L fluid /day
• Fluid restriction (eg, 1 - 1.5L /day) only in patients with
refractory HF or symptomatic or severe hyponatremia
ACE inhibitors
• Reduces mortality , they should be started in all patients
with heart failure unless contraindicated
• ACE inhibitors stabilize LV remodeling, improve
symptoms, reduce hospitalization, and improves quality of
life.
• T. Captopril 6.25 mg 6th hourly, increase up to 50 mg TID
• T. Enalapril 2.5 mg BD, increase up to 10 mg TID
• T. Ramipril 1.25 mg BD, increase up to 5 mg BD
• T. Losartan 25 - 50 mg OD
Betablocker
• These drugs can improve symptoms, exercise tolerance,
cardiac hemodynamics, and LV ejection fraction and that
they decrease mortality rates in patients with cardiac
failure, especially those with both ischemic and idiopathic
cardiomyopathy
• Start with very low dose, then slowly increase.
Digoxin
• Indicated in cardiac failure with associated atrial
fibrillation , it less effective when patients are in sinus
rhythm but it has been shown to reduce rates of
hospitalization for symptom control although there is no
significant effect on mortality
• T. Digoxin 0.125 -0.25 mg OD, 5 days in a week

More Related Content

What's hot

High Blood Pressure
High Blood PressureHigh Blood Pressure
High Blood Pressure
bajah423
 
Pathophsyology left ventricular failure
Pathophsyology left ventricular failurePathophsyology left ventricular failure
Pathophsyology left ventricular failure
Keren Shay
 

What's hot (20)

Cardiac arrhythmias
Cardiac arrhythmiasCardiac arrhythmias
Cardiac arrhythmias
 
Management of Heart failure
Management of Heart failureManagement of Heart failure
Management of Heart failure
 
Dobutamine
DobutamineDobutamine
Dobutamine
 
Beta blockers
Beta blockersBeta blockers
Beta blockers
 
Vasopressors
VasopressorsVasopressors
Vasopressors
 
Hypertension ( Increased blood pressure)
Hypertension ( Increased blood pressure) Hypertension ( Increased blood pressure)
Hypertension ( Increased blood pressure)
 
High Blood Pressure
High Blood PressureHigh Blood Pressure
High Blood Pressure
 
Pulmonary edema
Pulmonary edemaPulmonary edema
Pulmonary edema
 
Cardioversion
CardioversionCardioversion
Cardioversion
 
Frusemide
FrusemideFrusemide
Frusemide
 
Ckd ppt
Ckd pptCkd ppt
Ckd ppt
 
Vecuronium
VecuroniumVecuronium
Vecuronium
 
Nor adrenalin
Nor adrenalinNor adrenalin
Nor adrenalin
 
Pulmonary edema by Nadia Sarwar
Pulmonary edema by Nadia SarwarPulmonary edema by Nadia Sarwar
Pulmonary edema by Nadia Sarwar
 
Pathophsyology left ventricular failure
Pathophsyology left ventricular failurePathophsyology left ventricular failure
Pathophsyology left ventricular failure
 
Hypertension Physiology, Pathophysiology, Pharmacology, Therapeutics
Hypertension Physiology, Pathophysiology, Pharmacology, TherapeuticsHypertension Physiology, Pathophysiology, Pharmacology, Therapeutics
Hypertension Physiology, Pathophysiology, Pharmacology, Therapeutics
 
Cardiac failure
Cardiac failureCardiac failure
Cardiac failure
 
Adrenaline(1)
Adrenaline(1)Adrenaline(1)
Adrenaline(1)
 
Amiodarone
AmiodaroneAmiodarone
Amiodarone
 
Arrhythmias
ArrhythmiasArrhythmias
Arrhythmias
 

Similar to Pulmonary edema

Congestive heart failure
Congestive heart failure Congestive heart failure
Congestive heart failure
Ravi kumar
 
Congestive Heart Failure
Congestive Heart FailureCongestive Heart Failure
Congestive Heart Failure
wayn
 

Similar to Pulmonary edema (20)

Congestive heart failure
Congestive heart failureCongestive heart failure
Congestive heart failure
 
Congestive heart failure
Congestive heart failureCongestive heart failure
Congestive heart failure
 
Heart failure
Heart failureHeart failure
Heart failure
 
Cardiac heart failure
Cardiac heart failureCardiac heart failure
Cardiac heart failure
 
Congestive heart failure
Congestive heart failure Congestive heart failure
Congestive heart failure
 
Hf. final
Hf. finalHf. final
Hf. final
 
CHF.ppt
CHF.pptCHF.ppt
CHF.ppt
 
CONGESTIVE HEART FAILURE.pptx
CONGESTIVE HEART FAILURE.pptxCONGESTIVE HEART FAILURE.pptx
CONGESTIVE HEART FAILURE.pptx
 
Cardiovascular drugs
Cardiovascular drugsCardiovascular drugs
Cardiovascular drugs
 
Heart failure
Heart failureHeart failure
Heart failure
 
Congestive Heart Failure
Congestive Heart FailureCongestive Heart Failure
Congestive Heart Failure
 
Heart failure
Heart failureHeart failure
Heart failure
 
Case presentation on CAD
Case presentation on CADCase presentation on CAD
Case presentation on CAD
 
Chronic Heart Failure- Pharmacotherapy
Chronic Heart Failure-  PharmacotherapyChronic Heart Failure-  Pharmacotherapy
Chronic Heart Failure- Pharmacotherapy
 
Heart Failure
Heart FailureHeart Failure
Heart Failure
 
Angina
AnginaAngina
Angina
 
Heart failure
Heart failureHeart failure
Heart failure
 
Antihypertensives
AntihypertensivesAntihypertensives
Antihypertensives
 
2.1. Heart Failure.ppt
2.1. Heart  Failure.ppt2.1. Heart  Failure.ppt
2.1. Heart Failure.ppt
 
Congestive heart failure
Congestive heart failureCongestive heart failure
Congestive heart failure
 

Recently uploaded

New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
i3 Health
 

Recently uploaded (20)

New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
 
Multiple sclerosis diet.230524.ppt3.pptx
Multiple sclerosis diet.230524.ppt3.pptxMultiple sclerosis diet.230524.ppt3.pptx
Multiple sclerosis diet.230524.ppt3.pptx
 
Antiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptxAntiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptx
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
 
Impact of cancers therapies on the loss in cardiac function, myocardial fffic...
Impact of cancers therapies on the loss in cardiac function, myocardial fffic...Impact of cancers therapies on the loss in cardiac function, myocardial fffic...
Impact of cancers therapies on the loss in cardiac function, myocardial fffic...
 
Is preeclampsia and spontaneous preterm delivery associate with vascular and ...
Is preeclampsia and spontaneous preterm delivery associate with vascular and ...Is preeclampsia and spontaneous preterm delivery associate with vascular and ...
Is preeclampsia and spontaneous preterm delivery associate with vascular and ...
 
PT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptxPT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptx
 
Temporal, Infratemporal & Pterygopalatine BY Dr.RIG.pptx
Temporal, Infratemporal & Pterygopalatine BY Dr.RIG.pptxTemporal, Infratemporal & Pterygopalatine BY Dr.RIG.pptx
Temporal, Infratemporal & Pterygopalatine BY Dr.RIG.pptx
 
Presentació "Advancing Emergency Medicine Education through Virtual Reality"
Presentació "Advancing Emergency Medicine Education through Virtual Reality"Presentació "Advancing Emergency Medicine Education through Virtual Reality"
Presentació "Advancing Emergency Medicine Education through Virtual Reality"
 
TEST BANK For Advanced Practice Nursing in the Care of Older Adults, 2nd Edit...
TEST BANK For Advanced Practice Nursing in the Care of Older Adults, 2nd Edit...TEST BANK For Advanced Practice Nursing in the Care of Older Adults, 2nd Edit...
TEST BANK For Advanced Practice Nursing in the Care of Older Adults, 2nd Edit...
 
Aptopadesha Pramana / Pariksha: The Verbal Testimony
Aptopadesha Pramana / Pariksha: The Verbal TestimonyAptopadesha Pramana / Pariksha: The Verbal Testimony
Aptopadesha Pramana / Pariksha: The Verbal Testimony
 
Final CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptx
Final CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptxFinal CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptx
Final CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptx
 
Fundamental of Radiobiology -SABBU.pptx
Fundamental of Radiobiology  -SABBU.pptxFundamental of Radiobiology  -SABBU.pptx
Fundamental of Radiobiology -SABBU.pptx
 
Scientificity and feasibility study of non-invasive central arterial pressure...
Scientificity and feasibility study of non-invasive central arterial pressure...Scientificity and feasibility study of non-invasive central arterial pressure...
Scientificity and feasibility study of non-invasive central arterial pressure...
 
Contact dermaititis (irritant and allergic).pdf
Contact dermaititis (irritant and allergic).pdfContact dermaititis (irritant and allergic).pdf
Contact dermaititis (irritant and allergic).pdf
 
Effects of vaping e-cigarettes on arterial health
Effects of vaping e-cigarettes on arterial healthEffects of vaping e-cigarettes on arterial health
Effects of vaping e-cigarettes on arterial health
 
linearity concept of significance, standard deviation, chi square test, stude...
linearity concept of significance, standard deviation, chi square test, stude...linearity concept of significance, standard deviation, chi square test, stude...
linearity concept of significance, standard deviation, chi square test, stude...
 
TEST BANK For Wong’s Essentials of Pediatric Nursing, 11th Edition by Marilyn...
TEST BANK For Wong’s Essentials of Pediatric Nursing, 11th Edition by Marilyn...TEST BANK For Wong’s Essentials of Pediatric Nursing, 11th Edition by Marilyn...
TEST BANK For Wong’s Essentials of Pediatric Nursing, 11th Edition by Marilyn...
 
"Central Hypertension"‚ in China: Towards the nation-wide use of SphygmoCor t...
"Central Hypertension"‚ in China: Towards the nation-wide use of SphygmoCor t..."Central Hypertension"‚ in China: Towards the nation-wide use of SphygmoCor t...
"Central Hypertension"‚ in China: Towards the nation-wide use of SphygmoCor t...
 
180-hour Power Capsules For Men In Ghana
180-hour Power Capsules For Men In Ghana180-hour Power Capsules For Men In Ghana
180-hour Power Capsules For Men In Ghana
 

Pulmonary edema

  • 2. Pulmonary edema and cardiac failure • Pulmonary edema is fluid accumulation in the tissue and air spaces of the lungs. It leads to impaired gas exchange and may cause respiratory failure. • Cardiac failure is defined as a state in which the heart can not maintain an adequate cardiac output or can do so with an elevated filling pressure
  • 3. Left ventricular failure - and causes • In left ventricular systolic failure, there is reduced cardiac contractility, where as in diastolic heart failure there is impaired cardiac relaxation and abnormal ventricular filling. • Left ventricular systolic dysfunction - cases are due to chronic coronary artery disease, MI or chronic angina. Other causes of left ventricular systolic dysfunction include idiopathic dilated cardiomyopathy, valvular heart disease, hypertensive heart disease, toxin-induced cardiomyopathies (ie, alcohol and doxorubicin), and congenital heart disease.
  • 4. Triggers of cardiac failure • Infections, fever, sepsis , Anemia ,Beriberi ,Thyrotoxicosis • Cardiac arrhythmias, Infective endocarditis • Excess salt/fluid intake, Stress ,Electrolyte disturbances- potassium, magnesium • Steroids, NSAIDS • Negative inotropes e.g. Calcium channel blockers, such as verapamil & diltiazem, and Beta blockers
  • 5. Clinical features of cardiac failure Symptoms Signs Fatigue,Exercise intolerance Dyspnea on exertion Orthopnea, PND Presyncope, Syncope Palpitation Angina Pedal oedema Ascites Elevated JVP Hepatic congestion, Hepatosplenomegaly Pulmonary oedema(Basal crepitations)
  • 6. Investigations • Hb % (anaemia to be ruled out) • Thyroid function test • Electrolytes – potassium, magnesium, sodium • Serum creatinine (renal failure):
  • 7. Chest X ray (pulmonary oedema) • DD:Cardiogenic pulmonary edema, • ARDS,Viral pneumonia, Eosinophilic pneumonia,TB
  • 8. B-type natriuretic peptide • BNP is a 32 amino acid polypeptide secreted by the ventricles of the heart in response to excessive stretching of heart muscle cells • BNP is increased in patients with left ventricular dysfunction, with or without symptoms (BNP accurately reflects current ventricular status, as its half-life is 20 minutes, • Levels above 500 pg/ml are generally considered to be positive, Levels between 100 and 500 pg/ml the test is considered inconclusive • BNP can be elevated in renal failure, in the absence of heart failure.
  • 9. Other investigations • ECG (Ischaemic changes) • TMT (Ischaemic changes) in stable cases only • ECHO(Low Ejection fraction, valvular lesions) • USG abdomen (congestive hepatosplenomegaly)
  • 10. Acute management • Oxygen inhalation • Propped up position /45O head ed elevation • S/L Nitroglycerine and IV NTG (if BP is high) • IV Furosemide 40-80 mg IV , repeat if needed • Inotropes (NA/Dopamine, Dobutamine) in hypotension • Non invasive ventilation(BIPAP)
  • 11. Diuretics • Diuretics produces symptomatic relief • Start with a thiazide diuretic in very mild failure (Hydrochlorothiazide 12.5 – 25 mg) OR a loop diuretic (Furosemide 40mg : Lasix 40 ®) • Add a potassium-sparing agent, which can reduce potential hypokalemia (Spironolactone 25 mg) • Best option Furosemide + Spironolactone • Lasilactone ® (Frusemide/Spironolactone- 20mg/50mg)
  • 12. Ionotropes • Sympathomimetic agents – Dobutamine 2.5 – 15 mcg/kg/min infusion – Dopamine 2 – 8 mcg /kg /min infusion • Phosphodiesterase inhibitors – Milrinone 50 mcg/kg IV bolus over 10 minutes then 0.375 – 0.75 mcg/kg/min, – Amrinone. – Levosimendan
  • 13. Salt and water • 2 gm salt , 1 L fluid /day • Fluid restriction (eg, 1 - 1.5L /day) only in patients with refractory HF or symptomatic or severe hyponatremia
  • 14. ACE inhibitors • Reduces mortality , they should be started in all patients with heart failure unless contraindicated • ACE inhibitors stabilize LV remodeling, improve symptoms, reduce hospitalization, and improves quality of life. • T. Captopril 6.25 mg 6th hourly, increase up to 50 mg TID • T. Enalapril 2.5 mg BD, increase up to 10 mg TID • T. Ramipril 1.25 mg BD, increase up to 5 mg BD • T. Losartan 25 - 50 mg OD
  • 15. Betablocker • These drugs can improve symptoms, exercise tolerance, cardiac hemodynamics, and LV ejection fraction and that they decrease mortality rates in patients with cardiac failure, especially those with both ischemic and idiopathic cardiomyopathy • Start with very low dose, then slowly increase.
  • 16. Digoxin • Indicated in cardiac failure with associated atrial fibrillation , it less effective when patients are in sinus rhythm but it has been shown to reduce rates of hospitalization for symptom control although there is no significant effect on mortality • T. Digoxin 0.125 -0.25 mg OD, 5 days in a week